32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-03
DOI
10.1186/s12967-020-02462-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Frizzled‐Like Cysteine‐Rich Domain in Glypican‐3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice
- (2019) Na Li et al. HEPATOLOGY
- A safe and potent anti-CD19 CAR T cell therapy
- (2019) Zhitao Ying et al. NATURE MEDICINE
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era
- (2018) Hannah R. Robinson et al. BLOOD
- Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
- (2018) Min Yu et al. MOLECULAR THERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
- (2018) Ying Fu et al. HEPATOLOGY
- An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
- (2017) Takahiro Ishiguro et al. Science Translational Medicine
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
- (2016) Chunguang Wang et al. Oncotarget
- Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate
- (2016) Wei Gao et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Structural Aspects ofN-Glycosylations and the C-terminal Region in Human Glypican-1
- (2015) Wael Awad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
- (2015) Wei Gao et al. Nature Communications
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
- (2015) Wei Gao et al. PLoS One
- ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers
- (2014) B. G. Pierce et al. BIOINFORMATICS
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
- (2014) M. Capurro et al. JOURNAL OF CELL SCIENCE
- The role of glypicans in Hedgehog signaling
- (2014) Jorge Filmus et al. MATRIX BIOLOGY
- Antibody modeling using the Prediction of ImmunoGlobulin Structure (PIGS) web server
- (2014) Paolo Marcatili et al. Nature Protocols
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- Glypican-3 antibodies: A new therapeutic target for liver cancer
- (2013) Mingqian Feng et al. FEBS LETTERS
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis
- (2013) JuanPing Yu et al. Science China-Life Sciences
- High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
- (2012) Yen Phung et al. mAbs
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glypican-3: A new target for cancer immunotherapy
- (2010) Mitchell Ho et al. EUROPEAN JOURNAL OF CANCER
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
- (2008) J. E. Weldon et al. BLOOD
- Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation
- (2008) Ivan Stigliano et al. BREAST CANCER RESEARCH AND TREATMENT
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypicans
- (2008) Jorge Filmus et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started